Skip to main content
Clinical Trials/NL-OMON53002
NL-OMON53002
Completed
Not Applicable

Tailored treatment in Older Patients TOP-1: Omission of radiotherapy in elderly patients with low risk breast cancer - TOP-1

eids Universitair Medisch Centrum0 sites1,200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eids Universitair Medisch Centrum
Enrollment
1200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • \- age 70 years and older;
  • \- after breast conserving surgery
  • \- tumor \<1cm grade 1\-2 or tumor 1\-2cm grade 1;
  • \- tumor ER\>50% positive, HER2 negative;
  • \- sN0 or sN0(itc);
  • \- R0 resection;

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • \- indication for hormonal therapy;
  • \- bilateral.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 4
Optimising prescription of treatment in older patients with mild hypertension (high blood pressure) at increased risk of serious adverse eventsHypertensionCirculatory System
ISRCTN18030225niversity of Oxford3,014
Active, not recruiting
Not Applicable
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2013-001473-24-DEEli Lilly and Company880
Active, not recruiting
Not Applicable
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 17.0Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2013-001473-24-ATEli Lilly and Company880
Active, not recruiting
Phase 1
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUM
EUCTR2013-001473-24-GBEli Lilly and Company880
Recruiting
Not Applicable
Efficacy of the CARG Toxicity Score versus clinician estimate for predicting the risk of chemotherapy toxicity in older adults with cancer.
ACTRN12616000987460Dr Erin Moth150